Toxin-based selection of insulin-producing cells with improved defense properties for islet cell transplantation

Diabetes/Metabolism Research and Reviews

Volumn 21, Issue 3, 2005, Pages 253-261

  Bloch, Konstantin ^a   Vardi, Pnina ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Cell selection; Cytokines; Diabetogenic toxins; Insulin; Oxidative stress

Indexed keywords

ALLOXAN; CATALASE; CYTOKINE; GLUCOSE TRANSPORTER 2; GLUTATHIONE PEROXIDASE; HEAT SHOCK PROTEIN 70; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INSULIN; INTERLEUKIN 1 RECEPTOR; PROTEIN BCL 2; SOMATOSTATIN; STAT1 PROTEIN; STREPTOZOCIN; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR PDX 1;

ADOPTIVE IMMUNOTHERAPY; ALLOXAN DIABETES MELLITUS; AUTOIMMUNITY; CELL DIFFERENTIATION; CELL MEDIATED CYTOTOXICITY; CELL METABOLISM; CELL PROTECTION; CELL SELECTION; CELL SUBPOPULATION; CELLULAR IMMUNITY; DRUG MECHANISM; GENE EXPRESSION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN TREATMENT; NONHUMAN; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; STREPTOZOCIN DIABETES;

CELL SEPARATION; CYTOTOXINS; HUMANS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; OXIDATIVE STRESS;

EID: 19144369527     PISSN: 15207552     EISSN: None     Source Type: Journal    
DOI: 10.1002/dmrr.545     Document Type: Review

References (64)

1. Pipeleers D, Hoorens A, Marichal-Pipeleers M, et al. Role of pancreatic beta-cells in the process of beta-cell death. Diabetes 2001; 50(Suppl. 1): 52-57.
2. Robertson RP. Islet transplantation as a treatment for diabetes - a work in progress. N Engl J Med 2004; 350: 694-705.
3. Prokop A. Bioartificial pancreas: materials, devices, function, and limitations. Diabetes Technol Ther 2001; 3: 431-449.
4. King A, Andersson A, Sandler S. Cytokine-induced functional suppression of microencapsulated rat pancreatic islets in vitro. Transplantation 2000; 70: 380-383.
5. Benhamou PY, Moriscot C, Richard MJ, et al. Adenovirus-mediated catalase gene transfer reduces oxidant stress in human, porcine and rat pancreatic islets. Diabetologia 1998; 41: 1093-1100.
6. Moriscot C, Richard MJ, Favrot MC, Benhamou PY. Protection of insulin-secreting INS-1 cells against oxidative stress through adenoviral-mediated glutathione peroxidase overexpression. Diabetes Metab 2003; 2: 145-151.
7. Contreras JL, Bilbao G, Smyth C, et al. Gene transfer of the Bcl-2 gene confers cytoprotection to isolated adult porcine pancreatic islets exposed to xenoreactive antibodies and complement. Surgery 2001; 130: 166-174.
8. Papas KK, Colton CK, Gounarides JS, et al. NMR spectroscopy in beta cell engineering and islet transplantation. Ann N Y Acad Sci 2001; 944: 96-119.
9. Dupraz P, Rinsch C, Pralong WF, et al. Lentivirus-mediated Bcl-2 expression in betaTC-tet cells improves resistance to hypoxia and cytokine-induced apoptosis while preserving in vitro and in vivo control of insulin secretion. Gene Ther 1999; 6: 1160-1169.
10. Bloch K, Zemel R, Bloch O, Grief H, Vardi P. Streptozotocin and alloxan-based selection improves toxin resistance of insulin-producing RINm cells. Int J Exp Diabetes Res 2000; 1: 211-219.
11. Bloch K, Vardi P. Therapeutic differentiation of tumor-derived insulin-producing cells selected for resistance to diabetogenic drugs. Int J Exp Diabetes Res 2000; 1: 233-237.
12. Bloch K, Vorobeychik M, Yavriyants K, Vardi P. Streptozotocin-based selection of insulin-producing BTC-tet cells with improved defense properties. Diabetes 2004; 53(Suppl. 2): A378.
13. Bloch K, Voribeychyk M, Yavriyants K, Vardi P. Selection of insulin-producing RIN cells with improved resistance to oxidative stress. Biochem Pharmacol 2003; 65: 1797-1805.
14. Chen G, Hohmeier HE, Gasa R, et al. Selection of insulinoma cell lines with resistance to interleukin-1βmacrosdollar- and gamma-interferon-induced cytotoxicity. Diabetes 2000; 49: 562-570.
15. Tran VV, Chen G, Newgard CB, Hohmeier HE. Discrete and complementary mechanisms of protection of beta-cells against cytokine-induced and oxidative damage achieved by bcl-2 overexpression and a cytokine selection strategy. Diabetes 2003; 52: 1423-1432.
16. Lenzen S, Panten U. Alloxan: history and mechanism of action. Diabetologia 1988; 31: 337-342.
17. Weiss RB. Streptozocin: a review of its pharmacology, efficacy, and toxicity. Cancer Treat Rep 1982; 66: 427-438.
18. Schnedl WJ, Ferber S, Johnson JH, Newgard CB. STZ transport and cytotoxicity. Specific enhancement in GLUT2-expressing cells. Diabetes 1994; 43: 1326-1333.
19. Elsner M, Tiedge M, Guldbakke B, et al. Importance of the GLUT2 glucose transporter for pancreatic beta cell toxicity of alloxan. Diabetologia 2002; 45: 1542-1549.
20. Okamoto H, Takasawa S. Recent advances in the Okamoto model: the CD38-cyclic ADP-ribose signal system and the regenerating gene protein (Reg)-Reg receptor system in beta-cells. Diabetes 2002; 51: 462-473.
21. Tiedge M, Lortz S, Drinkgern J, Lenzen S. Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes 1997; 46: 1733-1742.
22. Eizirik DL, Pipeleers DG, Ling Z, et al. Major species differences between humans and rodents in the susceptibility to pancreatic beta-cell injury. Proc Natl Acad Sci U S A 1994; 91: 9253-9256.
23. Pipeleers D, Kiekens R, Ling Z, et al. Physiologic relevance of heterogeneity in the pancreatic beta-cell population. Diabetologia 1994; 37(Suppl. 2): 57-64.
24. Fernandez-Alvarez J, Barbera A, Nadal B, et al. Stable and functional regeneration of pancreatic beta-cell population in nSTZ-rats treated with tungstate. Diabetologia 2004; 47: 470-477.
25. Nielsen K, Karlsen AE, Deckert M, et al. Beta-cell maturation leads to in vitro sensitivity to cytotoxins. Diabetes 1999; 48: 2324-2332.
26. Gazdar AF, Chick WL, Oie HK, et al. Continuous, clonal, insulin- and somatostatin-secreting cell lines established from a transplantable rat islet cell tumor. Proc Natl Acad Sci U S A 1980; 77: 3519-3523.
27. White JW, Swartz FJ, Swartz AF. Excess glucose intake induces accelerated beta-cell polyploidization in normal mice: a possible deleterious effect. J Nutr 1985; 115: 271-278.
28. Bolzan AD, Bianchi MS. Genotoxicity of streptozotocin. Mutat Res 2002; 512: 121-134.
29. Fernandes A, King LC, Guz Y, et al. Differentiation of new insulin-producing cells is induced by injury in adult pancreatic islets. Endocrinology 1997; 138: 1750-1762.
30. Waxman S, Borden EC, Lotan R, et al. Differentiation therapy of cancer: laboratory and clinical investigations. Cancer Res 1993; 53: 4109-4115.
31. Jetten AM, Nervi C, Vollberg TM. Control of squamous differentiation in tracheobronchial and epidermal epithelial cells: role of retinoids. J Natl Cancer Inst Monogr 1992; 13: 93-100.
32. Prados J, Melguizo C, Marchal JA, et al. Therapeutic differentiation in a human rhabdomyosarcoma cell line selected for resistance to actinomycin D. Int J Cancer 1998; 75: 379-383.
33. Marchal JA, Prados J, Melguizo C, et al. GR-891: a novel 5-fluorouracil acyclonucleoside prodrug for differentiation therapy in rhabdomyosarcoma cells. Br J Cancer 1999; 79: 807-813.
34. Prados J, Melguizo C, Fernandez A, et al. Inverse expression of mdr1 and c-myc genes in a rhabdomyosarcoma cell line resistant to actinomycin D. J Pathol 1995; 180: 85-89.
35. Tiedge M, Lortz S, Munday R, Lenzen S. Protection against the co-operative toxicity of nitric oxide and oxygen free radicals by overexpression of antioxidant enzymes in bioengineered insulin-producing RINm5F cells. Diabetologia 1999; 42: 849-855.
36. Lortz S, Tiedge M, Nachtwey T, et al. Protection of insulin-producing RINm5F cells against cytokine-mediated toxicity through overexpression of antioxidant enzymes. Diabetes 2000; 49: 1123-1130.
37. Oliveira HR, Curi R, Carpinelli AR. Glucose induces an acute increase of superoxide dismutase activity in incubated rat pancreatic islets. Am J Physiol 1999; 276: 507-510.
38. Ling Z, Van de Casteele M, Eizirik DL, Pipeleers DG. Interleukin-1beta-induced alteration in a beta-cell phenotype can reduce cellular sensitivity to conditions that cause necrosis but not to cytokine-induced apoptosis. Diabetes 2000; 49: 340-345.
39. Laybutt DR, Kaneto H, Hasenkamp W, et al. Increased expression of antioxidant and antiapoptotic genes in islets that may contribute to beta-cell survival during chronic hyperglycemia. Diabetes 2002; 51: 413-423.
40. Mandrup-Poulsen T, Helqvist S, Wogensen LD, et al. Cytokine and free radicals as effector molecules in the destruction of pancreatic beta cells. Curr Top Microbiol Immunol 1990; 164: 169-193.
41. Horio F, Fukuda M, Katoh H, et al. Reactive oxygen intermediates in autoimmune islet cell destruction of the NOD mouse induced by peritoneal exudate cells (rich in macrophages) but not T cells. Diabetologia 1994; 37: 22-31.
42. Suarez-Pinzon WL, Szabo C, Rabinovitch A. Development of autoimmune diabetes in NOD mice is associated with the formation of peroxynitrite in pancreatic islet beta-cells. Diabetes 1997; 46: 907-911.
43. Rabinovitch A, Suarez-Pinzon WL. Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus. Biochem Pharmacol 1998; 55: 1139-1149.
44. Chen G, Hohmeier HE, Newgard CB. Expression of the transcription factor STAT-1 alpha in insulinoma cells protects against cytotoxic effects of multiple cytokines. J Biol Chem 2001; 276: 766-772.
45. Lazarow A. Spontaneous recovery from alloxan diabetes in the rat. Diabetes 1952; 21: 363-372.
46. Guz Y, Nasir I, Teitelman G. Regeneration of pancreatic beta cells from intra-islet precursor cells in an experimental model of diabetes. Endocrinology 2001; 142: 4956-4968.
47. Hamamoto Y, Tsuura Y, Fujimoto S, et al. Recovery of function and mass of endogenous beta-cells in streptozotocin-induced diabetic rats treated with islet transplantation. Biochem Biophys Res Commun 2001; 287: 104-109.
48. Jorns A, Klempnauer J, Tiedge M, Lenzen S. Recovery of pancreatic beta cells in response to long-term normoglycemia after pancreas or islet transplantation in severely streptozotocin diabetic adult rats. Pancreas 2001; 23: 186-196.
49. Eizirik DL, Sandler S. Functional restoration of cultured mouse pancreatic islets after in vitro exposure to alloxan. Pharmacol Toxicol 1988; 63: 396-399.
50. Dor Y, Brown J, Martinez OI, Melton DA. Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 2004; 429: 41-46.
51. Bonner-Weir S, Baxter LA, Schuppin GT, Smith FE. A second pathway for regeneration of adult exocrine and endocrine pancreas. A possible recapitulation of embryonic development. Diabetes 1993; 42: 1715-1720.
52. Xu G, Stoffers DA, Habener JF, Bonner-Weir S. Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats. Diabetes 1999; 48: 2270-2276.
53. Sharma A, Zangen DH, Reitz P, et al. The homeodomain protein IDX-1 increases after an early burst of proliferation during pancreatic regeneration. Diabetes 1999; 48: 507-513.
54. Dutrillaux MC, Portha B, Roze C, Hollande E. Ultrastructural study of pancreatic B cell regeneration in newborn rats after destruction by streptozotocin. Virchows Arch B Cell Pathol Incl Mol Pathol 1982; 39: 173-185.
55. Finegood DT, Weir GC, Bonner-Weir S. Prior streptozotocin treatment does not inhibit pancreas regeneration after 90% pancreatectomy in rats. Am J Physiol 1999; 276: 822-827.
56. Shapiro AM, Ryan EA, Lakey JR. Pancreatic islet transplantation in the treatment of diabetes mellitus. Best Pract Res Clin Endocrinol Metab 2001; 15: 241-264.
57. de Vos P, Hamel AF, Tatarkiewicz K. Considerations for successful transplantation of encapsulated pancreatic islets. Diabetologia 2002; 45: 159-173.
58. Lim F, Sun AM. Microencapsulated islets as bioartificial endocrine pancreas. Science 1980; 210: 908-910.
59. Soon-Shiong P, Heintz RE, Merideth N, et al. Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation. Lancet 1994; 343: 950-951.
60. Vorobeychik M, Yavrians K, Bloch O, et al. From in vitro to in vivo estimation of toxin-selected RINmS cells with improved insulin response. Diabetes 2004; 53(Suppl. 2): A615.
61. Cohen O, Einav Y, Cohen Y, et al. Implantation of rat insulinoma cell line into cyclosporine treated rats. Effect of the in vivo environment on beta-cell specific gene expression. Transplantation 2000; 69: 1464-1470.
62. Briaud I, Rouault C, Reach G, Poitout V. Long-term exposure of isolated rat islets of Langerhans to supraphysiologic glucose concentrations decreases insulin mRNA levels. Metabolism 1999; 48: 319-323.
63. Pociot F, Karlsen AE. Combined genome and proteome approach to identify new susceptibility genes. Am J Med Genet 2002; 115: 55-60.
64. Cardozo AK, Berthou L, Kruhoffer M, et al. Gene microarray study corroborates proteomic findings in rodent islet cells. J Proteome Res 2003; 2: 553-555.